Morgan Stanley: China Molybdenum (03993) Q2 Earnings Preview Meets Expectations; "Overweight" Rating Maintained

Stock Track
2025/07/15

Morgan Stanley affirms China Molybdenum's (03993.HK) second-quarter earnings preview aligns with projections. The mining giant anticipates first-half net profit between RMB 8.2 billion and RMB 9.1 billion, marking a robust 51% to 68% year-on-year surge. This implies Q2 net earnings of RMB 4.25 billion to RMB 5.15 billion, representing annual growth of 27% to 54%. The midpoint estimate of RMB 4.7 billion closely matches the institution's forecast.

Company leadership attributes this strong profit expansion to rising copper/cobalt prices alongside increased copper sales volumes. Morgan Stanley reiterated its "Overweight" stance on China Molybdenum's H-shares, accompanied by an HK$11.7 price target. The combination of favorable commodity pricing dynamics and operational execution continues to drive the firm's positive performance trajectory.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10